» Articles » PMID: 8638217

Triple Primary Malignant Neoplasms Including a Malignant Brain Tumor: Report of Two Cases and Review of the Literature

Overview
Journal Surg Neurol
Specialty Neurosurgery
Date 1996 Mar 1
PMID 8638217
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Two rare cases of triple primary malignant neoplasms (PMN), including malignant brain tumors, which were glioblastoma multiformes, are described.

Methods: The clinical characteristics and underlying genetic alterations in triple or more PMN, including malignant brain tumors are discussed with intensive review of the literature.

Results: The first patient, a 77-year-old male, suffered metachronously from tubular adenocarcinoma of the stomach, transitional cell carcinoma of the bladder, and glioblastoma in the brain. This glioblastoma had loss of heterozygosity in exons 7-8 in p53 gene. The second patient, a 68-year-old male, developed papillary adenocarcinoma of the lung, adenocarcinoma of the rectum, and glioblastoma in the brain during a period of 7 years. In 42 such cases described in the literature, age distribution demonstrated two characteristic peaks, one in the third decade and the other over 50 years of age. The younger group consisted mainly of Turcot's syndrome, and of a case of Li-Fraumeni familial cancer syndrome. On the other hand, neither of these hereditary cancer syndromes were contained in the elder group. Regarding the site of PMN, colorectal cancers were associated most frequently with malignant brain tumors, followed by stomach cancers, and thyroid cancers. Malignant brain tumors, mostly glioblastoma multiforme, tend to occur as the last tumor of triple or more PMN.

Conclusions: These results suggest that genetic background might play an important role in tumorigenesis of PMN in the younger group, whereas epigenetic factors would be more important in the older group. Characteristic organ association and factors influencing carcinogenesis, such as aging, environmental carcinogens, and underlying genetic alterations in these tumors are further discussed.

Citing Articles

Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.

Dadey D, Medress Z, Sharma M, Ugiliweneza B, Wang D, Rodrigues A J Neurooncol. 2023; 164(3):655-662.

PMID: 37792220 DOI: 10.1007/s11060-023-04460-x.


Synchronous and Metachronous Malignant Epithelial and Lymphoid Tumors: a Clinicopathologic Study of 10 Patients from a Major Tertiary Care Center in Pakistan.

Ud Din N, Ahmad Z, Minhas K, Uddin Z, Ahmed A Asian Pac J Cancer Prev. 2017; 18(8):2067-2072.

PMID: 28843223 PMC: 5697461. DOI: 10.22034/APJCP.2017.18.8.2067.


Outcome of patients with malignant glioma and synchronous or metachronous non-central nervous system primary neoplasms.

Hamza M, Kamiya-Matsuoka C, Liu D, Yuan Y, Puduvalli V J Neurooncol. 2015; 126(3):527-33.

PMID: 26566652 PMC: 5557044. DOI: 10.1007/s11060-015-1992-x.


A recommendation for the management of lesions of unknown malignancy in multiple primary malignant neoplasm patients: A case report.

Xia X, Cui K Oncol Lett. 2014; 8(6):2744-2746.

PMID: 25364458 PMC: 4214459. DOI: 10.3892/ol.2014.2601.


A novel combination of multiple primary carcinomas: urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma--report of a case and review of the literature.

Koutsopoulos A, Dambaki K, Datseris G, Giannikaki E, Froudarakis M, Stathopoulos E World J Surg Oncol. 2005; 3:51.

PMID: 16045793 PMC: 1226150. DOI: 10.1186/1477-7819-3-51.